Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Prophylaxis with REGEN-COV is not a substitute for vaccination against

  • 📣#ONCTWITTER, Important! FDA has authorized wider use of Regeneron monoclonal antibody combo REGEN-COV for high-risk ppl 12+ yrs & >88 lbs following exposure to #SARSCoV2. One dose ⬇️ risk of symptomatic #COVID19 by 81% in a placebo-controlled RCT. https://t.co/nOCI87pbKT - view on twitter